Figure 3: (A) Cortical and basal ganglia glucose uptake in resting FDG PET scans in unmedicated schizophrenics, (B) Typical antipsychotic showing increased basal ganglia uptake, (C) Atypical antipsychotic showing increased cortical uptake
|
|
Close |
|
Figure 3: (A) Cortical and basal ganglia glucose uptake in resting FDG PET scans in unmedicated schizophrenics, (B) Typical antipsychotic showing increased basal ganglia uptake, (C) Atypical antipsychotic showing increased cortical uptake
|
|